Microsoft collaborates with Nvidia to innovate Healthcare services with AI

You can find various AI services and tools on the Azure Marketplace

Reading time icon 2 min. read

Readers help support Windows Report. We may get a commission if you buy through our links. Tooltip Icon

Read our disclosure page to find out how can you help Windows Report sustain the editorial team Read more

An AI generated image of a healthcare robot made by Nvidia and Microsoft

Nvidia and Microsoft collaborate to improve and innovate the Healthcare system. Their AI, Cloud services, and computing tools can bring new opportunities for Healthcare providers, pharmaceutical companies, biotechnology pioneers, and medical device developers. After all, the AI can help calculate dosages, discover new materials, perform virtual trials, and more.

Nvidia is actively working with Microsoft on various AI tools

Nvidia developed an AI platform known as BioNeMo to accelerate drug discovery. It is powered by Nvidia DGX Cloud on Microsoft Azure. The platform simplifies the AI training using your data. Besides, it can analyze datasets to help developers deploy new AI models faster.

Scientists can use the Nvidia AI platform to find the right models for their processes. For example, they can use AI to find potential drug candidates, perform virtual trials, and develop medicine faster.

Besides Microsoft, Nvidia works with Flywheel, which developed a cloud-based platform to make it easier for professionals to prepare medical imaging data. Together, they want to create an automated way to classify anatomical studies. In addition, Nvidia and Microsoft developed Nvidia MONAI (Medical Open Network for AI) to speed up imaging data preparation.

MONAI and Nuance Precision Imaging Network (PIN) are working with multiple institutions to develop AI models for medical imaging analysis. For example, during the pandemic, Mass General Birgham used AI to predict the oxygen levels of symptomatic patients.

In addition, SOPHiA GENETICS can enhance SOPHiA DDM, its cloud-based platform, with the help of Nvidia Parabricks, a scalable genomics analysis software from the Nvidia Clara suite, and Microsoft Azure to develop a tool that analyses whole genomes. Also, they can improve treatment decisions and advance drug development.

Professionals can access various AI services and tools from the Azure Marketplace

Developers, researchers, and practitioners can access more Nvidia tools and services, such as the Nvidia AI enterprise platform, which includes Nvidia NIM, a set of microservices developed to speed up the process of AI deployment. Healthcare professionals can find the set on Azure Marketplace.

Ultimately, the collaboration between Nvidia and Microsoft will most likely democratize AI adoption and lead to discoveries and breakthroughs in the Healthcare sector. Hopefully, more tech giants will join the race to provide AI tools and platforms for healthcare professionals.

Do you think AI will become a dependable resource for the Healthcare sector? Let us know in the comments.

More about the topics: microsoft, nvidia